The largest database of trusted experimental protocols

Mil 6

Manufactured by STEMCELL
Sourced in Canada

The MIL-6 is a lab equipment product designed for cell culture applications. It is a multi-channel pipette that enables the simultaneous dispensing of liquid volumes across multiple wells or tubes. The MIL-6 is capable of handling a range of liquid volumes and can be used in various laboratory settings to improve efficiency and precision during cell culture experiments.

Automatically generated - may contain errors

6 protocols using mil 6

1

Vascular Endothelial Differentiation from ESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
2000 ESCs/ 35mm dish were differentiated into EBs for 11 days in 1.0% Base Methylcellulose (M3120, Stem Cell Technologies, Vancouver, CA), 15% FBS (Hyclone), 10ug/ml insulin (Sigma, St. Louis, MO), 100ug/ml mFGF2 (Invitrogen, Carlsbad, CA), 50ug/ml VEGF (Biolegend, San Diego, CA), 10 ng/mL mIL-6 (Invitrogen, Carlsbad, CA), 2 U/mL hEPO (Stem Cell Technologies, Vancouver, CA), 450 μM monothioglycerol (MTG, Sigma, St. Louis, MO). 125 d11 EBs were plated onto 35mm plates in ES-Cult Endothelial Collagen Medium (Stem Cell Technologies, Vancouver, CA) containing 50 ng/ml mVEGF, 100 ng/ml mFGF2, 10 ng/mL mIL-6, and 2 U/mL hEPO. Sprout formation was assessed 4 days later. EBs were scored in blinded fashion according to 4 standard classes based on vascular sprout formation: I- no sprout formation, II- few sprouts, III- many sprouts but no network, IV- many sprouts with network [41 (link)].
+ Open protocol
+ Expand
2

Hematopoietic Stem Cell Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
At day 5 post-infection, 5×103 cells/mL Sca1+/lin cells were plated in methyl-cellulose (MC) supplemented with mIL-3, mIL-6, and mSCF (Stem Cell Technologies, Vancouver, Canada). The number of colony-forming units (CFU) was determined on day 10 after plating. The cells were washed out for serial replating and FACS analysis. For the GFP-positive LT-HSCs (Sca1+/c-Kit+/lin/Flk2) 300 cells/well, ST-HSCs (Sca1+/c-Kit+/lin/Flk2+) 500 cells/well and for MPs (Sca1/c-Kit+/lin) 3×103 cells/well were plated. For the following plating rounds 2.5×103 cells/well were seeded. For platings with cell numbers lower than 2.5×103 cells/well, all cells were replated. In order to keep comparable the different samples the colony and the cell counts are reported to 200 cells seeded.
+ Open protocol
+ Expand
3

Colony Forming Assay for Murine and Human Leukemic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For a CFU on murine leukemic cells freshly thawed BM cells from DEK/CAN-positive leukemic mice and healthy empty vector transduced control transplanted mice were plated in semi-solid medium supplemented with mIL-3 (20 ng/mL), mIL-6 (20 ng/mL) and mSCF (100 ng/mL) (Stem-Cell Technologies). On day 10 after plating, the number of colonies was determined. Freshly thawed bone marrow cells derived from t(6;9)-positive AML patients were cultured in semi-solid medium (MethoCult™ H4434, Stem-Cell Technologies) in the presence of the indicated compounds for 14 days, and the colony number was determined in comparison to the untreated samples.
+ Open protocol
+ Expand
4

Hematopoietic Stem Cell Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
At day 2 post-infection, Sca1+/lin- cells were plated at 5 x 103 cells/mL in methyl-cellulose supplemented with mIL-3 (20 ng/mL), mIL-6 (20 ng/mL) and mSCF (100 ng/mL)(Stem-Cell Technologies, Vancouver, Canada). On day 10 after plating, the number of colony forming units (CFUs) was determined. After washing out from the methyl-cellulose, the cells were stained with specific antibodies for the detection of surface marker expression by FACS. 5 x 103 cells/ml were replated in methyl-cellulose, thus permitting determination of the serial replating potential.
+ Open protocol
+ Expand
5

Culturing Hematopoietic Cell Lines and Primary Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
32Dcl3 (here after named as 32D) and BA/F3 cells (ACC-411, ACC-300, DSMZ, 2018–01) were cultured as described previously [25 (link), 26 (link)]. TF-1 cells (ACC-334, DSMZ, 2018–01) were cultured using RPMI 1640/10%FCS/GM-CSF (5 ng/ml). All cell lines were routinely tested for mycoplasma using PCR. Authentication of cell lines was performed using qRT-PCR for murine or human housekeeping gene as well as cell surface expression of characteristic receptor expression pattern (CD34, CD11b, Gr-1) using FACS analysis. Primary murine cells were cultured in serum-free BIT9500 cell culture medium (Stem Cell Technologies, Vancouver, BC, Canada) supplemented with mIL-3 (10 ng/ml), mIL-6 (5 ng/ml) and mSCF (50 ng/ml). All cytokines were purchased form ImmunoTools, (Friesoythe, Germany). Further, lineage negative transgenic SCLtTA/Bcr-Abl BM cells were retrovirally infected using MSCV-ER-Hoxb8-Neo plasmid as described previously [27 (link)]. ER-HoxB8 derived immortalized progenitor cells were cultured in IMDM containing 10% FBS, 5% SCF-supernatant and 1% Pen-Strep and selected with G418 (1 mg/ml) for 1 week. FACS analysis for Gr-1, CD11b, B220, CD3 and Ter119 (BioLegend, Fell, Germany) were performed demonstrated the absence of mature cell surface markers.
+ Open protocol
+ Expand
6

Culturing Human and Murine Leukemic Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human cell lines were acquired from American Type Culture Collection (ATCC) or Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) and were cultured in RPMI 1640 (HL60, MOLM13) or DMEM (293T) supplemented with 10% fetal bovine serum, 1xpenicillin/streptomycin (Gibco) at 37°C and 5% CO2. Identification of all cell lines was independently confirmed by cytogenetics profiling. The human CD34+ MLL::AF9 transformed cells were maintained in IMDM with 20% FBS, 1xpenicillin/streptomycin (Gibco),1xβ-mercaptoethanol (Gibco), 6 μg/mL hIL3, 10 μg/mL hIL6, 10 μg/mL hSCF, 10 μg/mL TPO, and 10 μg/mL FLT3 (Stemcell Technologies) at 37°C and 5% CO2. The murine MLL::AF9 transformed leukemic cells were maintained in IMDM with 20% FBS, 1xpenicillin/streptomycin (Gibco), 1xβ-mercaptoethanol (Gibco), 6 μg/mL mIL3, 10 μg/mL mIL6, and 20 μg/mL mSCF (Stemcell Technologies) at 37°C and 5% CO2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!